BioCentury
ARTICLE | Clinical News

Vilazodone regulatory update

May 31, 2010 7:00 AM UTC

FDA accepted an NDA from Clinical Data for vilazodone to treat major depressive disorder (MDD). The acceptance triggered a €12.5 million ($15.6 million) milestone payment to Merck KGaA (Xetra:MRK, Da...